Treatment Considerations in Elderly Colorectal Cancer Patients

Por McCleary, Nadine Jackson
Publicado em 2010

In Reply

Por McCleary, Nadine J., Hurria, Arti, Meyerhardt, Jeffrey
Publicado em 2013

Safety and Effectiveness of Oxaliplatin-based Chemotherapy Regimens in Adults 75 Years and Older with Colorectal Cancer

Por McCleary, Nadine Jackson, Odejide, Oreofe, Szymonifka, Jackie, Ryan, David, Hezel, Aram, Meyerhardt, Jeffrey A.
Publicado em 2012

Osteonecrosis of the jaw associated with ziv-aflibercept

Por Mawardi, Hani, Enzinger, Peter, McCleary, Nadine, Manon, Reshma, Villa, Alessandro, Treister, Nathaniel, Woo, Sook-Bin
Publicado no J Gastrointest Oncol (2016)

Impact of smoking on patients with stage III colon cancer: Results from CALGB 89803

Por McCleary, Nadine Jackson, Niedzwiecki, Donna, Hollis, Donna, Saltz, Leonard B., Schaefer, Paul, Whittom, Renaud, Hantel, Alexander, Benson, Al, Goldberg, Richard, Meyerhardt, Jeffrey A.
Publicado em 2010

A stakeholder-driven approach to improve the informed consent process for palliative chemotherapy

Por Enzinger, Andrea C., Wind, Jennifer K., Frank, Elizabeth, McCleary, Nadine J., Porter, Laura, Cushing, Heather, Abbott, Caroline, Cronin, Christine, Enzinger, Peter C., Meropol, Neal J., Schrag, Deborah
Publicado no Patient Educ Couns (2017)

Feasibility of Computer-Based Self-Administered Cancer-Specific Geriatric Assessment in Older Patients With Gastrointestinal Malignancy

Por McCleary, Nadine J., Wigler, Devin, Berry, Donna, Sato, Kaori, Abrams, Thomas, Chan, Jennifer, Enzinger, Peter, Ng, Kimmie, Wolpin, Brian, Schrag, Deborah, Fuchs, Charles S., Hurria, Arti, Meyerhardt, Jeffrey A.
Publicado em 2013

Impact of Age on the Efficacy of Newer Adjuvant Therapies in Patients With Stage II/III Colon Cancer: Findings From the ACCENT Database

Por McCleary, Nadine J., Meyerhardt, Jeffrey A., Green, Erin, Yothers, Greg, de Gramont, Aimery, Van Cutsem, Eric, O'Connell, Michael, Twelves, Christopher J., Saltz, Leonard B., Haller, Daniel G., Sargent, Daniel J.
Publicado em 2013

Effect of Adjuvant Chemotherapy on Survival of Patients With Stage III Colon Cancer Diagnosed After Age 75 Years

Por Sanoff, Hanna K., Carpenter, William R., Stürmer, Til, Goldberg, Richard M., Martin, Christopher F., Fine, Jason P., McCleary, Nadine Jackson, Meyerhardt, Jeffrey A., Niland, Joyce, Kahn, Katherine L., Schymura, Maria J., Schrag, Deborah
Publicado em 2012

Prognostic utility of molecular factors by age at diagnosis of colorectal cancer

Por McCleary, Nadine J, Sato, Kaori, Nishihara, Reiko, Inamura, Kentaro, Morikawa, Teppei, Zhang, Xuehong, Wu, Kana, Yamauchi, Mai, Kim, Sun A, Sukawa, Yasutaka, Mima, Kosuke, Qian, Zhi Rong, Fuchs, Charles S, Ogino, Shuji, Meyerhardt, Jeffrey A
Publicado no Clin Cancer Res (2015)

Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803

Por Ogino, Shuji, Shima, Kaori, Meyerhardt, Jeffrey A., McCleary, Nadine J., Ng, Kimmie, Hollis, Donna, Saltz, Leonard B., Mayer, Robert J., Schaefer, Paul, Whittom, Renaud, Hantel, Alexander, Benson, Al B., Spiegelman, Donna, Goldberg, Richard M., Bertagnolli, Monica M., Fuchs, Charles S.
Publicado em 2011

Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: Results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients

Por Rubinson, Douglas A., Hochster, Howard S., Ryan, David P., Wolpin, Brian M., McCleary, Nadine Jackson, Abrams, Thomas A., Chan, Jennifer A., Iqbal, Syma, Lenz, Heinz J., Lim, Dean, Rose, Jeffrey, Bekaii-Saab, Tanios, Chen, Helen X., Fuchs, Charles S., Ng, Kimmie
Publicado em 2013

Phase II and Pharmacodynamic Study of Autophagy Inhibition Using Hydroxychloroquine in Patients With Metastatic Pancreatic Adenocarcinoma

Por Wolpin, Brian M., Rubinson, Douglas A., Wang, Xiaoxu, Chan, Jennifer A., Cleary, James M., Enzinger, Peter C., Fuchs, Charles S., McCleary, Nadine J., Meyerhardt, Jeffrey A., Ng, Kimmie, Schrag, Deborah, Sikora, Allison L., Spicer, Beverly A., Killion, Leah, Mamon, Harvey, Kimmelman, Alec C.
Publicado em 2014

Predictive and Prognostic Analysis of PIK3CA Mutation in Stage III Colon Cancer Intergroup Trial

Por Ogino, Shuji, Liao, Xiaoyun, Imamura, Yu, Yamauchi, Mai, McCleary, Nadine J., Ng, Kimmie, Niedzwiecki, Donna, Saltz, Leonard B., Mayer, Robert J., Whittom, Renaud, Hantel, Alexander, Benson, Al B., Mowat, Rex B., Spiegelman, Donna, Goldberg, Richard M., Bertagnolli, Monica M., Meyerhardt, Jeffrey A., Fuchs, Charles S.
Publicado em 2013

Efficacy, safety, pharmacokinetics and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: A phase II study

Por Zhu, Andrew X., Ancukiewicz, Marek, Supko, Jeffrey G., Sahani, Dushyant V., Blaszkowsky, Lawrence S., Meyerhardt, Jeffrey A., Abrams, Thomas A., McCleary, Nadine Jackson, Bhargava, Pankaj, Muzikansky, Alona, Sheehan, Susan, Regan, Eileen, Vasudev, Eamala, Knowles, Michelle, Fuchs, Charles S., Ryan, David P., Jain, Rakesh K., Duda, Dan G.
Publicado em 2013

Multicenter Phase II Study of Tivozanib (AV-951) and Everolimus (RAD001) for Patients With Refractory, Metastatic Colorectal Cancer

Por Wolpin, Brian M., Ng, Kimmie, Zhu, Andrew X., Abrams, Thomas, Enzinger, Peter C., McCleary, Nadine J., Schrag, Deborah, Kwak, Eunice L., Allen, Jill N., Bhargava, Pankaj, Chan, Jennifer A., Goessling, Wolfram, Blaszkowsky, Lawrence S., Supko, Jeffrey G., Elliot, Meaghan, Sato, Kaori, Regan, Eileen, Meyerhardt, Jeffrey A., Fuchs, Charles S.
Publicado em 2013